Bayer Decides Against Splitting Up Company For Now
By Dominic Chopping
Bayer won't break up the company into separate units just yet, Chief Executive Bill Anderson said.
"On the question of the company's structure and a possible break-up of the group, our answer is 'not now'--and this shouldn't be misunderstood as 'never'," Anderson said Tuesday.
The German pharmaceutical and agricultural conglomerate has been looking into various options for the group as it seeks to cut debt and boost its beleaguered share price.
Write to Dominic Chopping at dominic.chopping@wsj.com
(END) Dow Jones Newswires
March 05, 2024 02:06 ET (07:06 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
5 Things We Learned From the Q1 Earnings Season
-
After Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
What’s Happening In the Markets This Week
-
Can the Fed Declare Victory on Inflation?
-
The Best REITs to Buy
-
3 Hot Stocks to Buy That Still Look Undervalued
-
After Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
Today’s Market Volatility Could Provide Tomorrow’s Opportunities
-
40 of the Best Investment Picks
-
Tech Stock Dividends Are Changing the Face of Dividend Growth Investing
-
Roblox Earnings: Weakening Engagement Has Weighed On Growth
-
The Best Gaming Stocks to Buy